
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 9.26 | 9.55 | 471 |
| 160 | 9.25 | 9.83 | 300 |
| 1 | 9.21 | 9.84 | 200 |
| 0 | 0.00 | 9.86 | 301 |
| 0 | 0.00 | 9.95 | 300 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 9.26 | 9.55 | 471 |
| 160 | 9.25 | 9.83 | 300 |
| 1 | 9.21 | 9.84 | 200 |
| 0 | 0.00 | 9.86 | 301 |
| 0 | 0.00 | 9.95 | 300 |
| 0 | Total | Total | 0 |
| High | 9.65 |
| Low | 9.01 |
| UC Limit | 9.85 |
| LC Limit | 8.92 |
| 52 Week High | 31.40 |
| 52 Week Low | 8.16 |
| Face Value | 10.00 |
| All Time High | 214.00 |
| All Time Low | 8.16 |
| 20D Avg Volume | 38,393 |
| 20D Avg Delivery(%) | -- |
| Book Value Per Share | -- |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | 0.00 |
| TTM PE See historical trend | -- (High PE) |
| P/B See historical trend | 0.00 (Low P/B) |
| Sector PE | 58.23 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
6 out of 9 years Lasa Supergenerics has given negative returns in November.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| November | 18.64% (2020) | 12.67% | -17.76% | -7.65% | -0.88% |
Lasa Supergener Standalone March 2025 Net Sales at Rs 39.14 crore, up 71.53% Y-o-Y Jun 05 2025 03:16 PM
Lasa Supergener Standalone September 2024 Net Sales at Rs 39.39 crore, up 62.1% Y-o-Y Nov 21 2024 11:09 AM
Lasa Supergener Standalone June 2024 Net Sales at Rs 30.84 crore, up 0.91% Y-o-Y Aug 19 2024 11:51 AM
Lasa Supergener Standalone March 2024 Net Sales at Rs 22.82 crore, down 35.41% Y-o-Y Jun 11 2024 11:08 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 398113 | Price 10.57 | % Traded 0.79 |
| Qty 224606 | Price 10.65 | % Traded 0.45 |
| Qty 284542 | Price 17.28 | % Traded 0.58 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Lasa Supergener | 9.54 | 1.60 | 47.80 | - | 0.57 | -17.62 | -61.82 | -14 | 142 | 0.03 |
| Sun Pharma | 1,776.80 | -0.22 | 426,313.84 | 40.80 | 5.90 | 15.13 | -1.03 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,412.00 | 0.83 | 170,218.45 | 68.50 | 11.37 | 14.63 | 6.90 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,745.20 | 0.72 | 126,754.59 | 59.23 | 16.89 | 25.17 | 14.65 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,507.50 | 0.23 | 121,771.51 | 22.38 | 3.90 | 16.90 | 1.41 | 5,291 | 27,547 | 0.00 |